Medical Scientist Liaison (MSL) - West TN
Gilead Sciences
Summary
This is an opportunity for a field-based medical professional who is passionate about science, meaningful scientific exchange, and keeping patients at the center of the work they do. Our MSLs serve as trusted scientific partners to healthcare professionals across academic and community oncology settings. They bring clinical and scientific evidence into meaningful peer-to-peer discussions, respond to clinical questions, build credible relationships with opinion leaders and investigators, and bring important insights from the field back into the organization.
Job description
Our MSLs are strong cross-functional collaborators. They bring the voice of healthcare professionals and patients into the organization, share medical insights, and partner effectively across Medical Affairs and other functions. This includes building productive relationships and collaborating appropriately and compliantly with Commercial colleagues while maintaining the independence and scientific integrity of the Medical Affairs role.
Territories
West TN (Memphis/Jackson), MS, LA, AR, etc.
Job Responsibilities
- Approaches scientific engagements with curiosity and a learning mindset.
- Listens intentionally, asking thoughtful questions, and seeks to understand clinicians' perspectives, patient needs, care gaps, and challenges while uncovering meaningful, evidence-based insights that can help improve patient care.
- Can translate complex scientific and clinical evidence into clear, balanced, patient-focused scientific dialogue that is relevant to the clinician and their practice using approved resources to enhance the learning.
- Help healthcare professionals explore what the data mean in the context of patient care while maintaining scientific accuracy and objectivity.
- Scientifically curious and committed to continuous learning.
- Skilled at building trusted relationships and facilitating meaningful scientific dialogue.
- A collaborative partner who can work effectively across Medical Affairs and appropriately and compliantly with Commercial and other cross-functional partners.
- Comfortable operating independently across a large geography while remaining closely connected to the broader team.
- Leverages strong business acumen to support broader Medical Affairs initiatives through special projects.
- Demonstrates Gilead's core values: integrity, teamwork, accountability, excellence, and inclusion and Leadership Commitments: I own, I trust, I care, I listen and I am bold.
Travel
Up to 60% overnight travel, with weekend work required based on business needs, including scientific meetings and congresses. Travel may occasionally occur with limited notice.
Requirements
- Advanced degree (PharmD, PhD, MD, DO, NP/PA) required
- Relevant hematology oncology experience preferred
- Clinical practice and/or industry experience within breast oncology desirable
- Demonstrated ability to work independently
- Experience in preparing and delivering presentations is required
- Clinical patient contact experience is preferred
- Ability to travel > 60% of the time, occasionally with short notice, including some weekends
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Paid Time Off
- Annual Bonus
- Stock-Based Long-Term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.